 |
| | Business Summary: Cereplast, Inc. develops and commercializes bio-based resins in the United States. Its bio-resins are primarily made of renewable resources, such as corn, tapioca, wheat, and potatoes; and are used as substitutes for conventional and petroleum-based plastics in a various applications. | | | Address 3411-3433 W El Segundo Blvd
Hawthorne
, CA 90250
Phone: 310-676-5000
Fax: 310-676-5003
Website: http://www.cereplast.com
| | Auditor |
|---|
HJ Associates & Consultants
| | Transfer Agent |
|---|
U.S. Stock Transfer Corp.
| Employees: 58 ShareHolders: 218 | Founded: 2001 Domicile: Nevada | | | |
| | Cereplast, Inc. develops and commercializes bio-based resins in the United States. Its bio-resins are primarily made of renewable resources, such as corn, tapioca, wheat, and potatoes; and are used as substitutes for conventional and petroleum-based plastics in a various applications. The company's resins are also used in various conventional converting processes, including injection molding, thermoforming, blow film, blow molding, and extrusion. In addition, its products are used in various applications and markets, including automotive, consumer electronics, medical, cosmetic packaging, furniture, and construction. Further, Cereplast serves plastic converters in the foodservice disposable packaging market. The company was incorporated in 2001. It was formerly known as Biocorp North America, Inc. and changed its name to Cereplast, Inc. in 2005. Cereplast is headquartered in Hawthorne, California. | | History: INCORPORATED in Nevada Sept. 14, 2001, as Biocorp North America, Inc.; name changed to NAT-UR, Inc. July 19, 2004, and to Cereplast, Inc. Mar. 18, 2005. | | | | | | Capital Expenditures, thousand. US Dollars |
|---|
| Year | Amount | | 2007 | 1,419 |
| | | | | | Research and Development Expenditures, thousand. US Dollars |
|---|
| Year | Amount | | 2007 | 321 |
| | | | | |
|
Management
|
|---|
| Officers | Position |
|---|
| Frederic Scheer | Chairman, Chief Financial Officer, Chief Accounting Officer & Chief Executive Officer | | Randy G. Woefel | President & Chief Operating Officer | | Margaret McMurray | Chief Administrative Officer | | William Kelly | Chief Technology Officer | | Shriram Bagrodia | SR VP | | Jerome Raphanaud | SR VP | | Alec Pettigrew | SR VP | | Mark Barton | SR VP |
| | Directors |
|---|
| Stephan Garden | | Petros Kitsos | | Frederic Scheer | | Jacques Vincent | | Randy G. Woefel | | | |
| | | | Capitalization as of 06/30/2008: | | | | | Authorized Shares | Outstanding Shares |
|---|
| Common $0.001 par | 495,000,000 | 262,277,595 | | Preferred $0.001 par | 5,000,000 | None |
| | | | LONG TERM DEBT: $60,510. | | | | Common $0.001 par | | | |
Stockholders:
02/29/2008,
218.
| | PRINCIPAL STOCKHOLDERS: March 6, 2008, Frederic Scheer owned or controlled 43.0% of the Common. | | | |
Transfer Agent: U.S. Stock Transfer Corp.
Glendale
, CA | | | | OTC Bulletin Board( Primary): CERP | | | | Exchange | Year | High | Low |
|---|
| OTC Bulletin Board | 2008 | 0.7100 | 0.0700 | | OTC Bulletin Board | 2007 | 0.9500 | 0.1000 | | OTC Bulletin Board | 2006 | 1.5000 | 0.2900 | | OTC Bulletin Board | 2005 | 0.3100 | 0.1500 |
|
| | | | DIVIDENDS: Common $0.001 par: No cash.
Common split 33-for-1, Mar. 18, 2005. | | | | | |
| | Annual Report |
|---|
| | | Income Statement | |
| 2007 | 2006 |
|---|
| GROSS SALES | $2,348,068 | $836,729 | | Sales Discounts, Returns & Allowances | (168,070) | (110,278) | | NET SALES | 2,179,998 | 726,451 | | COST OF SALES | 2,090,730 | 641,602 | | GROSS PROFIT | 89,268 | 84,849 | | OPERATING EXPENSES |
|
| | Depreciation and Amortization | 373,687 | 147,820 | | Financing Discount Costs | 3,243,460 | 412,653 | | Marketing Expense | 252,275 | 358,242 | | Professional Fees | 856,705 | 413,115 | | Rent Expense | 367,276 | 168,359 | | Research & Development | 321,450 | 155,409 | | Salaries & Wages | 2,027,539 | 683,617 | | Salaries & Wages - Stock Based Compensation | 3,142,477 | 444,512 | | Other Operating Expenses | 1,429,672 | 633,405 | | TOTAL OPERATING EXPENSES | 12,014,541 | 3,417,132 | | Interest Income | 285,083 | 6,203 | | Interest Expense | (38,045) | (57,673) | | NET LOSS | $(11,678,235) | $(3,383,753) | | BASIC AND DILUTED LOSS PER SHARE | $(0.05) | $(0.02) |
| | | | Balance Sheet | |
| 2007 | 2006 |
|---|
| ASSETS |
|
| | Current Assets |
|
| | Cash | $8,593,714 | $205,023 | | Accounts Receivable, Net | 431,020 | 132,470 | | Inventory | 1,827,667 | 976,079 | | Prepaid Expenses and Other Current Assets | 67,590 | 48,059 | | Total Current Assets | 10,919,991 | 1,361,631 | | Net Property and Equipment | 2,251,595 | 1,201,482 | | Other Assets |
|
| | Restricted Cash | 72,892 | -- | | Investments | 500 | 500 | | Intangibles, Net | 18,721 | 23,841 | | Deposits | 30,478 | 26,344 | | Total Other Assets | 122,591 | 50,685 | | Total Assets | $13,294,177 | $2,613,798 | | LIABILITIES AND SHAREHOLDERS EQUITY |
|
| | Current Liabilities |
|
| | Accounts Payable | $600,289 | $766,950 | | Other Payable | 146 | 901 | | Accrued Expenses | 152,947 | 52,318 | | Credit Line | -- | 47,468 | | Other Notes Payable | -- | 617,666 | | Capital Leases, Current Portion | 71,812 | 56,640 | | Loan Payable, Current Portion | 11,139 | 10,413 | | Total Current Liabilities | 836,333 | 1,552,356 | | Captial Leases | 87,440 | 110,212 | | Loan Payable | 3,874 | 15,016 | | Common Stock, $0.001 par value | 259,302 | 203,267 | | Additional Paid in Capital | 28,730,547 | 8,718,157 | | Deferred Equity Offering Cost | -- | (3,040,125) | | Retained Earnings/(Deficit) | (16,623,319) | (4,945,085) | | Total Shareholders Equity | 12,366,530 | 936,214 | | Total Liabilities and Shareholders Equity | $13,294,177 | $2,613,798 |
| | | |
| | Interim Report
|
|---|
| | | Data Not Available | | | | | | | | | |
| | Pro Forma Report
|
|---|
| | | Data Not Available | | | | | | | | | |
| | Quarterly Report Information
|
|---|
| | | Quarterly Revenue, US$ |
|---|
| Year | Quarter | Revenue | | 2008 |
1 | 890,000 | | 2008 |
2 | 1,050,000 | | 2008 |
3 | 1,410,000 | | 2007 |
1 | 390,000 | | 2007 |
2 | 480,000 | | 2007 |
3 | 630,000 | | 2007 |
4 | 740,000 | | 2007 |
Full Year
| 2,180,000 | | 2006 |
1 | 120,000 | | 2006 |
2 | 160,000 | | 2006 |
3 | 170,000 | | 2006 |
Full Year
| 730,000 | | 2005 |
3 | 170,000 | | 2005 |
Full Year
| 540,000 | | 2004 |
Full Year
| 620,000 |
| | | | | | Quarterly Net Income, US$ |
|---|
| Year | Quarter | Revenue | | 2008 |
1 | Nil | | 2008 |
2 | Nil | | 2008 |
3 | Nil | | 2007 |
1 | Nil | | 2007 |
2 | Nil | | 2007 |
3 | Nil | | 2007 |
4 | Nil | | 2007 |
Full Year
| (11,680,000) | | 2006 |
1 | (420,000) | | 2006 |
2 | (570,000) | | 2006 |
3 | (1,140,000) | | 2006 |
Full Year
| (3,383,800) | | 2005 |
3 | (250,000) | | 2005 |
Full Year
| (1,119,000) | | 2004 |
Full Year
| (290,000) | | 2003 |
Full Year
| (190,000) |
| | | | | | Quarterly EPS, US$ |
|---|
| Year | Quarter | Revenue | | 2008 |
1 | (.01) | | 2008 |
2 | (.01) | | 2008 |
3 | (.01) | | 2007 |
1 | (.01) | | 2007 |
2 | (.01) | | 2007 |
3 | (.01) | | 2007 |
4 | (.03) | | 2007 |
Full Year
| (.05) | | 2006 |
1 | Nil | | 2006 |
2 | Nil | | 2006 |
3 | (.01) | | 2006 |
Full Year
| (.02) | | 2005 |
3 | Nil | | 2005 |
Full Year
| (.01) | | 2004 |
Full Year
| Nil |
| | | |
| |
|